SCHEMBL6176253

SCHEMBL6176253

C[C@]1(C(=O)O)CNC(=O)N1C(=O)O

nearest known ligand 0.30

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
GLA P06280 1/20 0.30
POLB P06746 1/20 0.30
GAA P10253 1/20 0.30
FFAR3 O14843 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7272643 0.83
SCHEMBL31694894 0.78 KDM4E (0.34) KDM4EALDH1A1GLAPOLBGAA
SCHEMBL20701902 0.72
SCHEMBL25297626 0.72
SCHEMBL25248570 0.68
SCHEMBL23201305 0.68 FFAR3 (0.34) KDM4EALDH1A1GLAPOLBGAA
SCHEMBL11684096 0.65
SCHEMBL3628025 0.61 ALDH1A1 (0.35) ALDH1A1POLB
SCHEMBL23858690 0.60 KDM4E (0.33) KDM4EALDH1A1GLAPOLBGAA
SCHEMBL23858688 0.60 KDM4E (0.33) KDM4EALDH1A1GLAPOLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1513523-A1 1,5-DISUBSTITUTED IMIDAZOLIDIN-2-ONE DERIVATIVES FOR USE AS EP4 RECEPTOR AGONISTS IN THE TREATMENT OF EYE AND BONE DISEASES Merck Frosst Canada & Co. (CA) 2005-03-16 EP disclosed
WO-2003103664-A1 1,5-DISUBSTITUTED IMIDAZOLIDIN-2-ONE DERIVATIVES FOR USE AS EP4 RECEPTOR AGONISTS IN THE TREATMENT OF EYE AND BONE DISEASES MERCK FROSST CANADA & CO. (CA) 2003-12-18 WO disclosed